Latest filing published 02 Mar 2023 for Abbott Laboratories, €90k.
John F. Ginascol, EXECUTIVE VICE PRESIDENT of Abbott Laboratories, the only company in the record, has 27 filings between June 5, 2019 and March 2, 2023. None falls in the last twelve months.
The 8 open-market sales total EUR 7,385,079, with a median of EUR 241,448. Two of them are from the same day, April 21, 2020: EUR 3,478,723 and EUR 2,109,738. The third, EUR 1,172,027, is from December 13, 2022. No purchase appears. The rest of the record is 14 share grants and 5 option exercises.
The year 2020 holds 12 filings, against 1 in 2019, 6 in 2021, 5 in 2022 and 3 in 2023. Filings are published a median of 2 days after the trade.
Of Ginascol's market trades, 7 fall within 30 days of a trade by Randel William Woodgrift and 6 of a trade by Christopher J. Scoggins, always in the same direction. Andrea F. Wainer, Daniel Gesua Sive Salvadori and Hubert L. Allen have 5 each, also in the same direction.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 27 declarations